Behind the headlines: what’s the real story for LMTX?
The UK public woke up yesturday morning to a series of headlines about phase III trial results of a potential Alzheimer’s drug called LMTX (also known as LMTM). The Times (£) placed their [...]
The UK public woke up yesturday morning to a series of headlines about phase III trial results of a potential Alzheimer’s drug called LMTX (also known as LMTM). The Times (£) placed their [...]
Experts at Adelaide’s Flinders University have made an Alzheimer’s breakthrough that may result in world’s first dementia vaccine. Developed by Australian and US scientists, this vaccine may not only prevent but also [...]